These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 27387538)

  • 41. Inhibitory Effects of Triptolide on Human Liver Cytochrome P450 Enzymes and P-Glycoprotein.
    Zhang H; Ya G; Rui H
    Eur J Drug Metab Pharmacokinet; 2017 Feb; 42(1):89-98. PubMed ID: 26874845
    [TBL] [Abstract][Full Text] [Related]  

  • 42.
    Ding B; Ji X; Sun X; Zhang T; Mu S
    Xenobiotica; 2020 Aug; 50(8):913-918. PubMed ID: 32026737
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cytochrome P450-mediated metabolism of the synthetic cannabinoids UR-144 and XLR-11.
    Nielsen LM; Holm NB; Olsen L; Linnet K
    Drug Test Anal; 2016 Aug; 8(8):792-800. PubMed ID: 26360322
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro inhibitory effects of bergenin on human liver cytochrome P450 enzymes.
    Dong G; Zhou Y; Song X
    Pharm Biol; 2018 Dec; 56(1):620-625. PubMed ID: 31070542
    [TBL] [Abstract][Full Text] [Related]  

  • 45.
    Li M; Liu X; Wang Y; Ju X
    Xenobiotica; 2020 Oct; 50(10):1202-1207. PubMed ID: 32338127
    [TBL] [Abstract][Full Text] [Related]  

  • 46.
    Li Y; Qin J; Wu H; Xu Y; Zhang L; Su K; Cui Y; Wang H
    Pharm Biol; 2020 Dec; 58(1):695-700. PubMed ID: 32673137
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity.
    Faucette SR; Hawke RL; Lecluyse EL; Shord SS; Yan B; Laethem RM; Lindley CM
    Drug Metab Dispos; 2000 Oct; 28(10):1222-30. PubMed ID: 10997944
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stereoselective Bupropion Hydroxylation by Cytochrome P450 CYP2B6 and Cytochrome P450 Oxidoreductase Genetic Variants.
    Wang PF; Neiner A; Kharasch ED
    Drug Metab Dispos; 2020 Jun; 48(6):438-445. PubMed ID: 32238417
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro inhibition of human liver cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT) enzymes by rose bengal: system-dependent effects on inhibitory potential.
    Kazmi F; Haupt LJ; Horkman JR; Smith BD; Buckley DB; Wachter EA; Singer JM
    Xenobiotica; 2014 Jul; 44(7):606-14. PubMed ID: 24405273
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro oxidative metabolism of cajaninstilbene Acid by human liver microsomes and hepatocytes: involvement of cytochrome p450 reaction phenotyping, inhibition, and induction studies.
    Hua X; Peng X; Tan S; Li C; Wang W; Luo M; Fu Y; Zu Y; Smyth H
    J Agric Food Chem; 2014 Oct; 62(43):10604-14. PubMed ID: 25272989
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Investigation of CYP2B6, 3A4 and β-esterase interactions of Withania somnifera (L.) dunal in human liver microsomes and HepG2 cells.
    Kumar S; Bouic PJ; Rosenkranz B
    J Ethnopharmacol; 2021 Apr; 270():113766. PubMed ID: 33395575
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of Phenoxyaniline Analogues To Generate Biochemical Insights into the Interactio n of Polybrominated Diphenyl Ether with CYP2B Enzymes.
    Chen C; Liu J; Halpert JR; Wilderman PR
    Biochemistry; 2018 Feb; 57(5):817-826. PubMed ID: 29215266
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ZY12201, A Potent TGR5 Agonist: Identification of a Novel Pan CYP450 Inhibitor Tool Compound for In-Vitro Assessment.
    Giri P; Gupta L; Rathod A; Joshi V; Giri S; Patel N; Agarwal S; R Jain M
    Drug Metab Lett; 2022 Mar; ():. PubMed ID: 35293300
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro Inhibitory Effects of Cynaroside on Human Liver Cytochrome P450 Enzymes.
    Wang L; Ma X; Wang J; Li C
    Pharmacology; 2019; 104(5-6):296-302. PubMed ID: 31587003
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human liver microsomal diazepam metabolism using cDNA-expressed cytochrome P450s: role of CYP2B6, 2C19 and the 3A subfamily.
    Ono S; Hatanaka T; Miyazawa S; Tsutsui M; Aoyama T; Gonzalez FJ; Satoh T
    Xenobiotica; 1996 Nov; 26(11):1155-66. PubMed ID: 8948091
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of artemisinin antimalarials on Cytochrome P450 enzymes in vitro using recombinant enzymes and human liver microsomes: potential implications for combination therapies.
    Ericsson T; Sundell J; Torkelsson A; Hoffmann KJ; Ashton M
    Xenobiotica; 2014 Jul; 44(7):615-26. PubMed ID: 24400699
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibitory Effects of Trapping Agents of Sulfur Drug Reactive Intermediates against Major Human Cytochrome P450 Isoforms.
    Sodhi JK; Delarosa EM; Halladay JS; Driscoll JP; Mulder T; Dansette PM; Khojasteh SC
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28726718
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    Zhang J; Li C; Zhang J; Zhang F
    Xenobiotica; 2019 Oct; 49(10):1127-1132. PubMed ID: 29676195
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro characterization of the metabolic pathways and cytochrome P450 inhibition and induction potential of BMS-690514, an ErbB/vascular endothelial growth factor receptor inhibitor.
    Hong H; Su H; Ma L; Yao M; Iyer RA; Humphreys WG; Christopher LJ
    Drug Metab Dispos; 2011 Sep; 39(9):1658-67. PubMed ID: 21673131
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of Cytochrome b5 Content on the Activity of Polymorphic CYP1A2, 2B6, and 2E1 in Human Liver Microsomes.
    Zhang H; Gao N; Liu T; Fang Y; Qi B; Wen Q; Zhou J; Jia L; Qiao H
    PLoS One; 2015; 10(6):e0128547. PubMed ID: 26046844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.